Navigation Links
Even 6 months or more of hormone therapy treatment does not impact longevity of prostate cancer patients

Prostate cancer patients who receive treatment by way of radiation or surgery with hormone therapy that goes above a 6 month period, does not impact longevity when compared// to patients who have received the treatment for a shorter duration, a recent study has revealed.

"Many patients with high risk prostate cancer are treated with two or more years of hormone therapy based on studies performed over a decade ago," said Cliff Robinson, M.D., lead author of the study and a radiation oncologist at Cleveland Clinic in Cleveland, Ohio. "Our study's findings suggest that treating current patients with shorter-term hormone therapy may not only be equally effective, but also improve their quality of life, due to a lesser degree of treatment side effects."

The authors also found that patients receiving longer than six months of hormone therapy were twice as likely to die as patients who use the treatment for a shorter amount of time. "The reasons why patients receiving longer term hormone therapy may do worse are unclear," said Dr. Robinson, who also cautions, "A number of factors could complicate the issue, and this area needs further investigation before any conclusions can be drawn."

Androgen deprivation therapy is a hormone therapy used to treat prostate cancer by lowering the level of male hormones (androgens) to shrink or slow down the growth of prostate cancer. It has been shown to dramatically slow advanced prostate cancer that has already spread to the lymph nodes or the bone, and improves survival when combined with radiation therapy in advanced prostate cancer that has not already spread.

Several side effects are common to androgen deprivation therapy and are a direct result of decreased androgen levels. Side effects vary significantly depending on the amount and length of time the hormone therapy is given. Potential side effects include reduced sexual desire, impotence, hot flashes, weakening of the bones, breast tenderness or breast growth, as well as other conditions.

The study reviewed 579 patients who were treated at the Cleveland Clinic with high risk prostate cancer from 1996 to 2003. These patients were divided into three groups - one that received no androgen deprivation therapy, one that had received six months or less of androgen deprivation therapy, and one that received more than six months of treatment - to determine if longer use of hormone therapy stopped cancer from growing and lengthened survival.

Source-Eurekalert
'"/>




Related medicine news :

1. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
2. Winter months encourage binge eating
3. Vitamin D Supplement in Teenage Girls essential in Winter months
4. Vitamin D Supplement in Teenage Girls essential in Winter months
5. NHS De-addiction, Rehabilitation waiting time ticking into months
6. HIV/AIDS prevention program extended by 18 months in Bangladesh
7. Thyroid hormone treatment hastens recovery after cardiac surgery
8. Breast feeding can alter hormones
9. Breast cancer risk doubles by high sex hormone levels
10. A hormone may decrease Menopause Symptoms
11. Alcohol injures stress hormone response
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... MAP Health ... this year’s Fierce Innovation Awards: Healthcare Edition 2017, an awards program from the ... of Population Health Management/Patient Engagement Solutions. , MAP was selected as a ...
(Date:7/27/2017)... , ... July 27, 2017 , ... Cremations recently surpassed ... Funeral Directors Association, this trend is expected to continue with over 70% of Americans ... a growing demand for new innovations that enable families to celebrate the life of ...
(Date:7/26/2017)... Miami, FL (PRWEB) , ... July 26, 2017 , ... ... caps that treat hereditary hair loss. The new Flexible Fitting Design offers a more ... of Capillus, LLC is delighted with the improvements to the home-use laser therapy caps ...
(Date:7/26/2017)... Madison, WI (PRWEB) , ... July 26, 2017 ... ... launch of Talent Management Solutions as part of their continued efforts to provide ... retain, and develop the best IT resources and build dynamic, high-performing teams to ...
(Date:7/26/2017)... PA (PRWEB) , ... July 26, 2017 , ... “We ... said Dr. Ahmed Mauassra, from San Jose, Calif., “so we invented the MAGNETIC/ LOCK ... the bracket portion of orthodontic braces. In doing so, it offers an effective alternative ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO ... quarter 2017 operating results on Monday, August 7, 2017 ... at 5:00 p.m. ET. ... live broadcast of the conference call by dialing 877-201-0168 ... 51641230 approximately 15 minutes prior to the call. A ...
(Date:7/21/2017)... 21, 2017 Did you know that PhRMA member companies ... that combined spending on brand medicines, generics and the supply chain ... accounting for just half of this (7 percent)? Or that ... the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: